A share price of Quest Diagnostics, Inc [DGX] is currently trading at $186.82, down -0.08%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The DGX shares have gain 2.51% over the last week, with a monthly amount glided 4.57%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Quest Diagnostics, Inc [NYSE: DGX] stock has seen the most recent analyst activity on August 25, 2025, when Robert W. Baird downgraded its rating to a Neutral but kept the price target unchanged to $194 for it. Previously, Redburn Atlantic started tracking the stock with Buy rating on April 02, 2025, and set its price target to $195. On March 04, 2025, downgrade downgraded it’s rating to Neutral but maintained its price target of $185 on the stock. Leerink Partners upgraded its rating to a Outperform and increased its price target to $174 on January 06, 2025. Morgan Stanley upgraded its rating to a Overweight and raised its price target to $172 on December 17, 2024. In a note dated October 23, 2024, Robert W. Baird upgraded an Outperform rating on this stock and boosted its target price from $157 to $182.
Quest Diagnostics, Inc experienced fluctuations in its stock price throughout the past year between $146.17 and $187.96. Currently, Wall Street analysts expect the stock to reach $191.33 within the next 12 months. Quest Diagnostics, Inc [NYSE: DGX] shares were valued at $186.82 at the most recent close of the market. An investor can expect a potential return of 2.41% based on the average DGX price forecast.
Analyzing the DGX fundamentals
Trailing Twelve Months sales for Quest Diagnostics, Inc [NYSE:DGX] were 10.52B which represents 15.19% growth. Gross Profit Margin for this corporation currently stands at 0.33% with Operating Profit Margin at 0.14%, Pretax Profit Margin comes in at 0.12%, and Net Profit Margin reading is 0.09%. To continue investigating profitability, this company’s Return on Assets is posted at 0.06, Equity is 0.14 and Total Capital is 0.1. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.88.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 185.89 points at the first support level, and at 184.97 for the second support level. However, for the 1st resistance point, the stock is sitting at 187.83, and for the 2nd resistance point, it is at 188.85.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Quest Diagnostics, Inc [NYSE:DGX] is 1.09. Also, the Quick Ratio is 0.99, while the Cash Ratio stands at 0.16. Considering the valuation of this stock, the price to sales ratio is 1.99, the price to book ratio is 2.89 and price to earnings (TTM) ratio is 22.34.
Transactions by insiders
Recent insider trading involved PREVOZNIK MICHAEL E, Officer, that happened on Sep 24 ’25 when 175.0 shares were purchased. Officer, PREVOZNIK MICHAEL E completed a deal on Sep 23 ’25 to buy 28288.0 shares. Meanwhile, SVP for Diagnostic Services Plewman Patrick sold 1975.0 shares on Aug 21 ’25.
